GLOW – Regenerative Peptide Blend
GHK-Cu (50 mg) + BPC-157 (10 mg) + TB-500 (10 mg)
Multi-Pathway Tissue Repair, Anti-Inflammatory and Regenerative Research Formula
GLOW is a research-grade peptide blend designed to explore synergistic tissue regeneration, extracellular matrix remodeling, angiogenesis, and systemic recovery signaling.
By combining GHK-Cu, BPC-157, and TB-500, GLOW targets complementary biological pathways involved in wound healing, connective-tissue repair, inflammation control, and cellular migration.
This blend is widely applicable in experimental models of musculoskeletal injury, skin and soft-tissue repair, vascular recovery, and systemic inflammatory stress.
Composition
-
GHK-Cu (Copper Tripeptide-1) — 50 mg
-
BPC-157 (Body Protection Compound-157) — 10 mg
-
TB-500 (Thymosin Beta-4 fragment) — 10 mg
Specifications
-
Product type: Multi-peptide regenerative blend
-
Class: Tissue repair / angiogenic / cytoprotective research compound
-
Primary research domains:
-
Wound healing
-
Tendon, ligament, and muscle repair
-
Skin regeneration and collagen remodeling
-
Inflammation and oxidative stress modulation
-
Angiogenesis and endothelial repair
-
Mechanistic Overview – Why This Blend Works
GLOW is engineered to address all major phases of tissue repair:
-
Inflammation control
-
Cell migration and angiogenesis
-
Matrix remodeling and collagen synthesis
-
Long-term tissue integrity and regeneration
Each peptide contributes a distinct, non-redundant mechanism, resulting in true biological synergy, not overlap.
Component 1 – GHK-Cu (Copper Tripeptide-1)
Gene Modulation, Collagen Remodeling & Anti-Inflammatory Signaling
GHK-Cu is a naturally occurring human tripeptide that binds copper (II) ions and acts as a master regulator of regenerative gene expression.
Key Research Effects
-
Upregulates genes involved in collagen I & III synthesis
-
Activates fibroblasts, keratinocytes, and endothelial cells
-
Enhances angiogenesis and wound closure
-
Suppresses NF-κB–mediated inflammation
-
Reduces oxidative stress via SOD activation
Transcriptomic studies show GHK-Cu can positively regulate thousands of genes associated with tissue repair while downregulating pro-fibrotic and inflammatory pathways.
Component 2 – BPC-157 (Body Protection Compound-157)
Cytoprotection, Vascular Repair & Inflammation Control
BPC-157 is a stable gastric pentadecapeptide extensively studied for its organ-protective and reparative properties.
Key Research Effects
-
Accelerates tendon-to-bone healing
-
Enhances angiogenesis and microvascular integrity
-
Protects endothelial cells and nitric-oxide signaling
-
Reduces inflammatory cytokines (TNF-α, IL-6)
-
Promotes healing in muscle, ligament, gut, and nerve tissue
BPC-157 is notable for its ability to stabilize damaged tissue environments, making it an ideal foundation peptide in regenerative blends.
Component 3 – TB-500 (Thymosin Beta-4 Fragment)
Cell Migration, Actin Remodeling & Systemic Tissue Repair
TB-500 is a synthetic fragment of thymosin beta-4, a peptide involved in actin regulation and cell motility.
Key Research Effects
-
Promotes cell migration to injury sites
-
Enhances angiogenesis and capillary formation
-
Reduces fibrosis and scar tissue formation
-
Improves muscle fiber regeneration
-
Modulates inflammatory signaling
TB-500 plays a crucial role in the proliferative and remodeling phases of healing by guiding cells to damaged tissue.
Synergistic Action of the GLOW Blend
Why GHK-Cu + BPC-157 + TB-500 Together?
| Healing Phase | Dominant Peptide | Role |
|---|---|---|
| Inflammation control | BPC-157 + GHK-Cu | Cytoprotection, cytokine suppression |
| Cell migration | TB-500 | Actin remodeling, cellular movement |
| Angiogenesis | All three | Vascular growth & stability |
| Collagen remodeling | GHK-Cu | ECM synthesis and organization |
| Long-term tissue integrity | GHK-Cu + BPC-157 | Structural repair & resilience |
This coordinated activity allows GLOW to function as a full-spectrum regenerative research blend, rather than a single-pathway compound.
Experimental Applications
GLOW is commonly explored in research models involving:
-
Muscle tears and strain recovery
-
Tendon and ligament injury
-
Post-surgical tissue repair
-
Skin regeneration and wound healing
-
Chronic inflammation and oxidative stress
-
Vascular injury and endothelial dysfunction
Research Use Only – Important Notice
GLOW (GHK-Cu 50 mg + BPC-157 10 mg + TB-500 10 mg) is supplied exclusively for laboratory research purposes.
-
Not for human or veterinary use
-
Not for diagnostic, therapeutic, or cosmetic applications
-
Intended only for in vitro studies and/or controlled experimental animal models
-
All descriptions summarize preclinical and mechanistic research and do not constitute medical claims




Reviews
There are no reviews yet.